IFP Advisors’s CareDx CDNA Stock Holding History
Bought
Maintained
Sold
Other funds holding CDNA
DM
AIM
GS
IFP Advisors's CDNA Position: Q2 2026 in Review
IFP Advisors reduced its CareDx (CDNA) stake by 20% in Q2 2026, selling an estimated $479 and leaving 88 shares worth $2.51K. The position accounts for ﹤0.01% of the portfolio, ranked #4134.
IFP Advisors first reported a position in CDNA in Q1 2016 and has held it in 23 quarters since. The position peaked at $291K in Q3 2018. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.
- IFP Advisors held 88 shares of CareDx worth $2.51K as of Q2 2026.
- IFP Advisors sold 22 CareDx shares in Q2 2026, an estimated $479.
- CareDx made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4134 holding.
- IFP Advisors first reported a position in CareDx in Q1 2016 and has held it in 23 quarters since.
- IFP Advisors's CareDx position peaked at $291K in Q3 2018.
- 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.